Related Experiment Video

Updated: Jun 8, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

Unfractionated heparin during elective PCI: fixed dose or weight adjusted?

Ananth Kidambi1, Gnanamoorthy Mayurathan, Girish Viswanathan

  • 1Department of Cardiology, Freeman Hospital and Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne, UK.

Cardiovascular Therapeutics
|October 16, 2010
PubMed

Insights

A fixed dose of unfractionated heparin (UFH) during elective percutaneous coronary intervention (PCI) showed similar troponin levels and safety outcomes compared to weight-adjusted doses. This suggests a potentially lower UFH dose may be sufficient for PCI procedures.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Pharmacology

Background:

  • Optimal unfractionated heparin (UFH) dosing for elective percutaneous coronary intervention (PCI) in stable angina patients remains unclear.
  • Current guidelines lack robust data, necessitating further investigation into heparin strategies.
  • Transradial PCI is increasingly common, requiring specific procedural anticoagulation assessment.

Purpose of the Study:

  • To compare the efficacy and safety of a fixed UFH dose versus a weight-adjusted UFH dose during elective transradial PCI.
  • To evaluate troponin I release as the primary endpoint for assessing myocardial injury.
  • To determine if a reduced heparin dose is non-inferior to standard dosing in this patient population.

Main Methods:

  • Retrospective analysis of a PCI database including 698 patients with stable angina undergoing elective transradial PCI.
  • Patients were divided into two groups: fixed UFH dose (3000 U) and weight-adjusted UFH dose (70 U/kg).
  • Primary endpoint was troponin I release; secondary endpoints included ischemic events and bleeding complications.

Main Results:

  • No significant difference in median troponin I levels between the fixed-dose (0.17 ng/mL) and weight-adjusted dose (0.14 ng/mL) groups (P=0.21).
  • Similar proportions of troponin-positive patients were observed in both groups (61.9% vs. 58.1%; P=0.37).
  • No deaths, major ischemic events, or bleeding complications requiring transfusion or delaying discharge occurred.

Conclusions:

  • A reduced, fixed dose of periprocedural UFH is associated with similar post-PCI troponin levels compared to standard weight-adjusted dosing.
  • These findings challenge the necessity of standard weight-adjusted heparin dosing in elective transradial PCI.
  • Further clinical trials are warranted to definitively establish optimal UFH dosage for PCI.
Abstract

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...